A Phase II Study of Conversion Surgery After IP Paclitaxel With XELOX Chemotherapy in AGC With Peritoneal Dissemination

NCT04797923 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Advanced Gastric Cancer
Peritoneal Carcinomatosis

Interventions

DRUG: 1. Treatment: IP chemotherapy + Systemic chemotherapy
PROCEDURE: 2. Response evaluation after 4 cycles of IP + systemic chemotherapy

Sponsor

Gangnam Severance Hospital